Galectin Therapeutics Inc.GALTNASDAQ
Loading
Operating Income ContractionContracting
Percentile Rank27
Studio
Year-over-Year Change

Profit from core business operations before interest and taxes

Latest
$-29.15M
Near historical average
Percentile
P27
Within normal range
Streak
1 yr
Consecutive growthContracting
Average
$-26.64M
Historical baseline
PeriodValueYoY Change
TTM$-29.15M+31.3%
2024$-42.43M-11.5%
2023$-38.07M+0.7%
2022$-38.35M-27.1%
2021$-30.18M-28.7%
2020$-23.44M-74.5%
2019$-13.44M+1.2%
2018$-13.60M+16.3%
2017$-16.25M+24.4%
2016$-21.48M-